Inactive Instrument
Sector Epigenomics AG Deutsche Boerse AG
Stocks
DE000A0BVT96
Biotechnology & Medical Research
|
End-of-day quote
Deutsche Boerse AG
|
||
| - EUR | - |
|
| 09-03 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.59% | +10.04% | +22.92% | +160.61% | +273.26% | +397.07% | +102.38% | -58.56% | +22.62% | 4.62B | |
| -2.62% | +12.43% | +7.20% | +58.93% | +71.55% | +108.53% | +437.84% | -27.79% | - | 4.45B | |
| +4.33% | +0.75% | -1.87% | -22.58% | -1.38% | +21.72% | +83.72% | -15.56% | +493.14% | 3.34B | |
| +0.93% | +3.74% | +11.77% | +107.52% | +188.38% | +272.38% | +601.03% | -15.44% | +1,296.66% | 2.81B | |
| +6.75% | +15.41% | +0.43% | +19.31% | -6.57% | -16.39% | -19.04% | -53.91% | - | 2.43B | |
| -2.98% | +10.96% | +20.20% | +49.68% | +27.40% | +56.60% | - | - | - | 1.78B | |
| +0.89% | +6.73% | +11.80% | +22.66% | +43.28% | +28.20% | +62.00% | -46.30% | +95.42% | 1.13B | |
| +2.87% | +7.26% | -17.01% | +37.88% | +120.62% | +165.56% | -28.59% | -84.65% | - | 1.07B | |
| +5.23% | +1.37% | +11.56% | -8.96% | -58.76% | -15.35% | +65.52% | - | - | 604M | |
| +2.22% | +5.72% | -2.11% | +5.70% | -26.51% | -31.36% | -18.62% | -40.40% | - | 531M | |
| +12.55% | +51.73% | +7.49% | +25.04% | -64.33% | +18.47% | - | - | - | 317M | |
| -0.43% | -2.52% | -6.45% | -0.43% | -26.11% | +4.50% | -63.00% | -70.03% | -37.86% | 166M | |
| +0.25% | -0.25% | -7.60% | -26.29% | -46.53% | +17.60% | +24.53% | -94.82% | -95.61% | 131M | |
| -1.36% | +14.62% | -13.19% | -29.99% | -74.19% | -36.42% | - | - | - | 109M | |
| -0.47% | +0.16% | -9.59% | +6.22% | -7.20% | -24.49% | -24.54% | -25.56% | - | 106M | |
| -2.82% | -1.43% | -22.76% | -37.96% | -45.24% | -61.09% | -78.10% | -95.26% | -99.82% | 94.97M | |
| -0.24% | -2.38% | -9.69% | -38.21% | -64.19% | -42.94% | - | - | - | 91.66M | |
| -2.45% | +0.36% | -2.45% | +15.32% | +26.59% | +22.69% | +16.04% | -23.49% | - | 90.18M | |
| +0.87% | +2.87% | -1.50% | -21.04% | -43.71% | -4.37% | -51.36% | - | - | 56.45M | |
| Average | +1.21% | +6.36% | -0.05% | +17.02% | +15.07% | +46.36% | +73.99% | -50.14% | +239.22% | 1.26B | |
| Weighted average by Cap. | +1.06% | +8.70% | +8.24% | +59.55% | +92.62% | +141.80% | +203.17% | -39.24% | +445.56% |
- Stock Market
- Stocks
- ECX Stock
- Stock
- Sector Epigenomics AG
Select your edition
All financial news and data tailored to specific country editions
